AVITA Medical (AVHHL) Net Margin (2018 - 2026)
AVITA Medical's (AVHHL) quarterly Net Margin came in at 35.31% in Q2 2026, up 1855.0% on a YoY basis from 1.81% in Q2 2025, and down 2205.56% quarter-over-quarter from 1.53% in Q4 2025.
Powered by 
Analysis
AVITA Medical (AVHHL) Net Margin (2018 - 2026) Analysis & Trends
AVITA Medical (AVHHL) has reported Net Margin for 9 consecutive years, with 35.31% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Margin rose 1855.0% year-over-year to 35.31%; the trailing twelve-month figure through Jun 2026 stood at 21.57% (up 2990.0% YoY), and the FY2025 full-year result was 53.59%, up 2239.0% from the prior year.
- Net Margin slipped to 35.31% in Q2 2026 per AVHHL's latest filing, from 1.53% in the prior quarter.
- Across five years, Net Margin topped out at 7.83% in Q4 2024 and bottomed at 168.03% in Q1 2024.
- Historically, Net Margin has averaged 70.07% across 5 years, with a median of 69.35% in 2023.
- The sharpest annual moves came in 2024 and 2025: Net Margin plunged 8064 bps in 2024, then soared 9317 bps in 2025.
- Over 5 years, Net Margin stood at 44.1% in 2022, then slumped by 43 bps to 63.11% in 2023, then jumped by 112 bps to 7.83% in 2024, then sank by 120 bps to 1.53% in 2025, then plunged by 2206 bps to 35.31% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 35.31%, 1.53%, and 77.29% for Q2 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.62 Bn | 179.02 Bn | 7.27 Bn | 7.37% |
| 2 | Intuitive Surgical | 124.22 Bn | 119.01 Bn | 1.96 Bn | 28.46% |
| 3 | Medtronic | 118.38 Bn | 109.56 Bn | 6.34 Bn | 15.17% |
| 4 | Stryker | 104.98 Bn | 101.51 Bn | 4.50 Bn | 19.37% |
| 5 | Boston Scientific | 66.67 Bn | 66.13 Bn | 3.85 Bn | 16.67% |
| 6 | Edwards Lifesciences | 49.77 Bn | 45.52 Bn | 1.35 Bn | 13.87% |
| 7 | Alcon | 34.01 Bn | 32.56 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.28 Bn | 30.33 Bn | 830.00 Mn | 19.04% |
| 9 | Steris | 21.17 Bn | 20.69 Bn | 684.20 Mn | 13.47% |
| 10 | AVITA Medical | 61.85 Mn | 50.72 Mn | 17.77 Mn | -35.31% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -35.31% |
| Dec 31, 2025 | -1.53% |
| Sep 30, 2025 | -77.29% |
| Jun 30, 2025 | -53.86% |
| Mar 31, 2025 | -74.86% |
| Dec 31, 2024 | 7.83% |
| Sep 30, 2024 | -82.91% |
| Jun 30, 2024 | -101.30% |
| Mar 31, 2024 | -168.03% |
| Dec 31, 2023 | -63.11% |
| Sep 30, 2023 | -63.85% |
| Jun 30, 2023 | -88.35% |
| Mar 31, 2023 | -87.39% |
| Dec 31, 2022 | -44.10% |
| Sep 30, 2022 | -61.46% |
| Mar 31, 2022 | -125.52% |
| Sep 30, 2021 | -63.87% |
| Jun 30, 2021 | -56.19% |
| Mar 31, 2021 | -68.42% |
| Dec 31, 2020 | -110.54% |